2022 was a challenging year for the tech industry and the economy as a whole, with high and persistent inflation causing significant growth and performance issues.
Outlook Therapeutics, Inc. (NASDAQ: OTLK) is a New Jersey-based clinical-stage biopharma company. It is ranked fifth on our list of 10 cheapest stocks on Robinhood.